Shari Pilon-Thomas

11PUBLICATIONS
118CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersGene and molecular therapyMechanobiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Mar 27, 2026
Cancer-selective photoimmunotherapy spares T cells and NK cells and promotes antitumor immunity in an allogeneic human 3D culture model.

Rebecca C Harman, Ivonne Lozano, Kristiana Ramos

|Dec 03, 2025
Rethinking the seven-day treatment-free interval in T-cell engager therapy using agent-based modeling.

Nina Obertopp, Matthew Froid, Shari Pilon-Thomas

|Jun 24, 2025
PV-10 Triggers Immunogenic Cell Death in Head and Neck Squamous Cell Carcinoma via Endoplasmic Reticulum Stress and Apoptosis.

Sowjanya Thatikonda, Ritu Chaudhary, Yeva Meshkovska

|Apr 18, 2025
Antitumor CD4+ T Helper 1 Cells Target and Control the Outgrowth of Disseminated Cancer Cells.

Ganesan Ramamoorthi, Marie Catherine Lee, Carly M Farrell

|Apr 08, 2025
CD40L stimulates tumor-infiltrating B-cells and improves ex vivo TIL expansion.

Renata Ariza Marques Rossetti, Leticia Tordesillas, Matthew S Beatty

|Apr 24, 2024
First-in-Human Stage III/IV Melanoma Clinical Trial of Immune Priming Agent IFx-Hu2.0.

Joseph Markowitz, Michael Shamblott, Andrew S Brohl

Pageof 2

Frequent Collaborators

3 joint publications

Amod Sarnaik

3 joint publications

James J Mulé

2 joint publications

MacLean S Hall

2 joint publications

Vernon K Sondak